Janney Montgomery Scott LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$67,000
-88.5%
22,916
-89.2%
0.00%
-83.3%
Q4 2017$581,000
+1470.3%
212,019
+1845.1%
0.01%
Q3 2017$37,000
+37.0%
10,900
-1.8%
0.00%
Q2 2017$27,000
+3.8%
11,100
-3.5%
0.00%
Q1 2017$26,000
+8.3%
11,5030.0%0.00%
Q4 2016$24,000
-79.5%
11,503
-67.0%
0.00%
-100.0%
Q3 2016$117,000
-7.9%
34,858
-2.9%
0.00%
-33.3%
Q4 2015$127,000
-41.7%
35,904
-17.3%
0.00%
-50.0%
Q3 2015$218,000
-99.9%
43,439
+4.2%
0.01%0.0%
Q2 2015$268,089,000
+90165.7%
41,693
-1.1%
0.01%0.0%
Q1 2015$297,000
-99.9%
42,157
+29.1%
0.01%
+20.0%
Q4 2014$251,732,000
+7.9%
32,650
+4.5%
0.01%0.0%
Q3 2014$233,400,000
-27.4%
31,245
-5.9%
0.01%
-28.6%
Q2 2014$321,415,000
+14.0%
33,204
-2.1%
0.01%0.0%
Q1 2014$281,967,000
+0.6%
33,931
+2.2%
0.01%0.0%
Q4 2013$280,183,000
+6.4%
33,197
+0.5%
0.01%
-12.5%
Q3 2013$263,378,00033,0460.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders